| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |